Zomedica Completes Internal “Launch Team” for Upcoming TRUFORMA™ Commercialization
07 déc. 2020 06h01 HE
|
Zomedica Corp.
ANN ARBOR, Mich., Dec. 07, 2020 (GLOBE NEWSWIRE) -- Zomedica Corp. (NYSE American: ZOM) (“Zomedica” or the “Company”), a veterinary health company creating point-of-care diagnostics products for...
Zomedica Sets March 30, 2021 as Expected Commercialization Date for TRUFORMA™
13 nov. 2020 06h00 HE
|
Zomedica Corp.
ANN ARBOR, Mich., Nov. 13, 2020 (GLOBE NEWSWIRE) -- Zomedica Corp. (NYSE American: ZOM) (“Zomedica” or the “Company”), a veterinary health company creating point-of-care diagnostics products for...
Zomedica Announces Third Quarter 2020 Financial Results
12 nov. 2020 06h30 HE
|
Zomedica Pharmaceuticals Corp.
ANN ARBOR, Mich., Nov. 12, 2020 (GLOBE NEWSWIRE) -- Zomedica Corp. (NYSE American:ZOM) (“Zomedica” or “Company”) today reported consolidated financial results for the third quarter ended September...
Zomedica Announces Letter From Robert Cohen, Interim CEO, Made Available to Shareholders in Connection With Special Virtual-Only Meeting
26 oct. 2020 09h25 HE
|
Zomedica Pharmaceuticals Corp.
ANN ARBOR, Mich., Oct. 26, 2020 (GLOBE NEWSWIRE) -- Zomedica Corp. (NYSE American: ZOM) announced today that the following letter from Robert Cohen, Interim Chief Executive Officer, has been made...
Zomedica Announces Name Change
02 oct. 2020 17h05 HE
|
Zomedica Pharmaceuticals Corp.
ANN ARBOR, Mich., Oct. 02, 2020 (GLOBE NEWSWIRE) -- Zomedica Corp. (formerly Zomedica Pharmaceuticals Corp.) (NYSE American: ZOM) (“Zomedica” or the “Company”), a veterinary health company creating...
Zomedica Announces Shareholder Meeting Voting Results
25 sept. 2020 11h00 HE
|
Zomedica Pharmaceuticals Corp.
ANN ARBOR, Mich., Sept. 25, 2020 (GLOBE NEWSWIRE) -- Zomedica Pharmaceuticals Corp. (NYSE American: ZOM) (“Zomedica” or the “Company”), a veterinary health company creating point-of-care diagnostics...
Zomedica Announces Letter to Shareholders in Connection With Annual and Special Virtual-Only Meeting
14 sept. 2020 17h44 HE
|
Zomedica Pharmaceuticals Corp.
ANN ARBOR, Mich., Sept. 14, 2020 (GLOBE NEWSWIRE) -- Zomedica Pharmaceuticals Corp. (NYSE American: ZOM) announced today that its proxy solicitor, Alliance Advisors, mailed the following letter to...
Zomedica Announces Presentation at Upcoming H.C. Wainwright Virtual Global Investment Conference
10 sept. 2020 06h55 HE
|
Zomedica Pharmaceuticals Corp.
ANN ARBOR, Mich., Sept. 10, 2020 (GLOBE NEWSWIRE) -- Zomedica Pharmaceuticals Corp. (NYSE American: ZOM), a veterinary health company creating point-of-care diagnostics products for companion...
Zomedica to Develop Gastrointestinal Testing Panel for TRUFORMA™
08 sept. 2020 06h55 HE
|
Zomedica Pharmaceuticals Corp.
ANN ARBOR, Mich., Sept. 08, 2020 (GLOBE NEWSWIRE) -- Zomedica Pharmaceuticals Corp. (NYSE American: ZOM) announced today that it has agreed with its development partner Qorvo Biotechnologies, LLC,...
Zomedica Announces Letter From Robert Cohen, Interim CEO, Made Available to Shareholders in Connection With Annual and Special Virtual-Only Meeting
27 août 2020 06h55 HE
|
Zomedica Pharmaceuticals Corp.
ANN ARBOR, Mich., Aug. 27, 2020 (GLOBE NEWSWIRE) -- Zomedica Pharmaceuticals Corp. (NYSE American: ZOM) announced today that the following letter from Robert Cohen, Interim Chief Executive Officer,...